[Hysteroscopic injection in sentinel node biopsy for endometrial cancer increases the frequency of para-aortic drainage: Is it necessary to reconsider the role of para-aortic lymphadenectomy?].
In cancer research, regional lymph node status is a major prognostic factor and a decision criterion for adjuvant therapy. The sentinel node procedure, which has emerged to reduce morbidity of extensive lymphadenectomy, remains a major step in the surgical management of various cancers. In endometrial cancer, the sentinel node biopsy is still at the stage of feasibility. The main problem of the diffusion of the sentinel node biopsy in endometrial cancer is the absence of injection site consensus. The different injection sites (myometrial, pericervical and hysteroscopy) allow to identify para-aortic lymph node drainage. In this article, we review the interest of hysteroscopic injection in endometrial cancer. This injection site could contribute to select the patients potentially being able to profit from a lombo-aortic lymphadenectomy.
Clément
Denys
D
Service de gynécologie-obstétrique, hôpital Lariboisière, 2, rue Ambroise-Paré, 75010 Paris.
Morel
Olivier
O
Malartic
Cécile
C
Akerman
Grégory
G
Barranger
Emmanuel
E
D016889:Endometrial Neoplasms / Q000473:pathology*; D005260:Female; D006801:Humans; D008196:Lymph / Q000502:physiology*; D008197:Lymph Node Excision; D009367:Neoplasm Staging / Q000379:methods; D021701:Sentinel Lymph Node Biopsy / Q000379:methods*